GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Il Yang Pharmaceutical Co Ltd (XKRX:007570) » Definitions » Research & Development

Il Yang Pharmaceutical Co (XKRX:007570) Research & Development : ₩29,615 Mil (TTM As of Sep. 2024)


View and export this data going back to 1974. Start your Free Trial

What is Il Yang Pharmaceutical Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Il Yang Pharmaceutical Co's Research & Development for the three months ended in Sep. 2024 was ₩9,586 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was ₩29,615 Mil.


Il Yang Pharmaceutical Co Research & Development Historical Data

The historical data trend for Il Yang Pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Il Yang Pharmaceutical Co Research & Development Chart

Il Yang Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15,849.51 19,723.27 20,195.55 25,960.09 27,439.23

Il Yang Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,958.77 6,318.48 7,321.57 6,389.63 9,585.76

Il Yang Pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩29,615 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Il Yang Pharmaceutical Co  (XKRX:007570) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Il Yang Pharmaceutical Co Research & Development Related Terms

Thank you for viewing the detailed overview of Il Yang Pharmaceutical Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Il Yang Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
110, hagal-ro, Giheung-gu, Yongin-si, Seoul, Gyeonggi, KOR
Il Yang Pharmaceutical Co Ltd operates in the Korean healthcare sector. The company is mainly a pharmaceutical product manufacturer. Its business is comprised of four product divisions, which are Medicines, Food, Cosmetics, and Antacid raw materials. Its medicines include anticancer and antibiotics and drugs for the liver, digestive system, and anti-inflammatory drugs. Its Foods division is engaged in the manufacture and sale of food supplements and health drinks.

Il Yang Pharmaceutical Co Headlines

No Headlines